Cargando…
Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide
BACKGROUND: Protective immunity against cholera is serogroup specific. Serogroup specificity in Vibrio cholerae is determined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). Generally, polysaccharides are poorly immunogenic, especially in young children. METHODOLOGY: Here we repo...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916310/ https://www.ncbi.nlm.nih.gov/pubmed/24516685 http://dx.doi.org/10.1371/journal.pntd.0002683 |
_version_ | 1782302690523480064 |
---|---|
author | Alam, Mohammad Murshid Bufano, Megan Kelly Xu, Peng Kalsy, Anuj Yu, Y. Freeman, Y. Wu Sultana, Tania Rashu, Md. Rasheduzzaman Desai, Ishaan Eckhoff, Grace Leung, Daniel T. Charles, Richelle C. LaRocque, Regina C. Harris, Jason B. Clements, John D. Calderwood, Stephen B. Qadri, Firdausi Vann, W. F. Kováč, Pavol Ryan, Edward T. |
author_facet | Alam, Mohammad Murshid Bufano, Megan Kelly Xu, Peng Kalsy, Anuj Yu, Y. Freeman, Y. Wu Sultana, Tania Rashu, Md. Rasheduzzaman Desai, Ishaan Eckhoff, Grace Leung, Daniel T. Charles, Richelle C. LaRocque, Regina C. Harris, Jason B. Clements, John D. Calderwood, Stephen B. Qadri, Firdausi Vann, W. F. Kováč, Pavol Ryan, Edward T. |
author_sort | Alam, Mohammad Murshid |
collection | PubMed |
description | BACKGROUND: Protective immunity against cholera is serogroup specific. Serogroup specificity in Vibrio cholerae is determined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). Generally, polysaccharides are poorly immunogenic, especially in young children. METHODOLOGY: Here we report the evaluation in mice of a conjugate vaccine for cholera (OSP:TThc) made from V. cholerae O1 Ogawa O-Specific Polysaccharide–core (OSP) and recombinant tetanus toxoid heavy chain fragment (TThc). We immunized mice intramuscularly on days 0, 21, and 42 with OSP:TThc or OSP only, with or without dmLT, a non-toxigenic immunoadjuvant derived from heat labile toxin of Escherichia coli. PRINCIPAL FINDINGS: We detected significant serum IgG antibody responses targeting OSP following a single immunization in mice receiving OSP:TThc with or without adjuvant. Anti-LPS IgG responses were detected following a second immunization in these cohorts. No anti-OSP or anti-LPS IgG responses were detected at any time in animals receiving un-conjugated OSP with or without immunoadjuvant, and in animals receiving immunoadjuvant alone. Responses were highest following immunization with adjuvant. Serum anti-OSP IgM responses were detected in mice receiving OSP:TThc with or without immunoadjuvant, and in mice receiving unconjugated OSP. Serum anti-LPS IgM and vibriocidal responses were detected in all vaccine cohorts except in mice receiving immunoadjuvant alone. No significant IgA anti-OSP or anti-LPS responses developed in any group. Administration of OSP:TThc and adjuvant also induced memory B cell responses targeting OSP and resulted in 95% protective efficacy in a mouse lethality cholera challenge model. CONCLUSION: We describe a protectively immunogenic cholera conjugate in mice. Development of a cholera conjugate vaccine could assist in inducing long-term protective immunity, especially in young children who respond poorly to polysaccharide antigens. |
format | Online Article Text |
id | pubmed-3916310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39163102014-02-10 Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide Alam, Mohammad Murshid Bufano, Megan Kelly Xu, Peng Kalsy, Anuj Yu, Y. Freeman, Y. Wu Sultana, Tania Rashu, Md. Rasheduzzaman Desai, Ishaan Eckhoff, Grace Leung, Daniel T. Charles, Richelle C. LaRocque, Regina C. Harris, Jason B. Clements, John D. Calderwood, Stephen B. Qadri, Firdausi Vann, W. F. Kováč, Pavol Ryan, Edward T. PLoS Negl Trop Dis Research Article BACKGROUND: Protective immunity against cholera is serogroup specific. Serogroup specificity in Vibrio cholerae is determined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). Generally, polysaccharides are poorly immunogenic, especially in young children. METHODOLOGY: Here we report the evaluation in mice of a conjugate vaccine for cholera (OSP:TThc) made from V. cholerae O1 Ogawa O-Specific Polysaccharide–core (OSP) and recombinant tetanus toxoid heavy chain fragment (TThc). We immunized mice intramuscularly on days 0, 21, and 42 with OSP:TThc or OSP only, with or without dmLT, a non-toxigenic immunoadjuvant derived from heat labile toxin of Escherichia coli. PRINCIPAL FINDINGS: We detected significant serum IgG antibody responses targeting OSP following a single immunization in mice receiving OSP:TThc with or without adjuvant. Anti-LPS IgG responses were detected following a second immunization in these cohorts. No anti-OSP or anti-LPS IgG responses were detected at any time in animals receiving un-conjugated OSP with or without immunoadjuvant, and in animals receiving immunoadjuvant alone. Responses were highest following immunization with adjuvant. Serum anti-OSP IgM responses were detected in mice receiving OSP:TThc with or without immunoadjuvant, and in mice receiving unconjugated OSP. Serum anti-LPS IgM and vibriocidal responses were detected in all vaccine cohorts except in mice receiving immunoadjuvant alone. No significant IgA anti-OSP or anti-LPS responses developed in any group. Administration of OSP:TThc and adjuvant also induced memory B cell responses targeting OSP and resulted in 95% protective efficacy in a mouse lethality cholera challenge model. CONCLUSION: We describe a protectively immunogenic cholera conjugate in mice. Development of a cholera conjugate vaccine could assist in inducing long-term protective immunity, especially in young children who respond poorly to polysaccharide antigens. Public Library of Science 2014-02-06 /pmc/articles/PMC3916310/ /pubmed/24516685 http://dx.doi.org/10.1371/journal.pntd.0002683 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Alam, Mohammad Murshid Bufano, Megan Kelly Xu, Peng Kalsy, Anuj Yu, Y. Freeman, Y. Wu Sultana, Tania Rashu, Md. Rasheduzzaman Desai, Ishaan Eckhoff, Grace Leung, Daniel T. Charles, Richelle C. LaRocque, Regina C. Harris, Jason B. Clements, John D. Calderwood, Stephen B. Qadri, Firdausi Vann, W. F. Kováč, Pavol Ryan, Edward T. Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide |
title | Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide |
title_full | Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide |
title_fullStr | Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide |
title_full_unstemmed | Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide |
title_short | Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide |
title_sort | evaluation in mice of a conjugate vaccine for cholera made from vibrio cholerae o1 (ogawa) o-specific polysaccharide |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916310/ https://www.ncbi.nlm.nih.gov/pubmed/24516685 http://dx.doi.org/10.1371/journal.pntd.0002683 |
work_keys_str_mv | AT alammohammadmurshid evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT bufanomegankelly evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT xupeng evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT kalsyanuj evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT yuy evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT freemanywu evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT sultanatania evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT rashumdrasheduzzaman evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT desaiishaan evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT eckhoffgrace evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT leungdanielt evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT charlesrichellec evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT larocquereginac evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT harrisjasonb evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT clementsjohnd evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT calderwoodstephenb evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT qadrifirdausi evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT vannwf evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT kovacpavol evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide AT ryanedwardt evaluationinmiceofaconjugatevaccineforcholeramadefromvibriocholeraeo1ogawaospecificpolysaccharide |